Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reck

Showing results (1251-1260 of 1,518) with videos related to

Pageof 152
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 23, 2020
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)Yung-Jue Bang, Talia Golan, Laetitia Dahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Molecular Cancer Therapeutics|January 27, 2016
Bevacizumab Prevents Brain Metastases Formation in Lung AdenocarcinomaAysegül Ilhan-Mutlu, Matthias Osswald, Yunxiang Liao, et al.
JTO Clinical and Research Reports|November 24, 2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Takashi Seto, Martin Reck, et al.
Biomedicines|November 25, 2023
Circulating Total Extracellular Vesicles Cargo Are Associated with Age-Related Oxidative Stress and Susceptibility to Cardiovascular Diseases: Exploratory Results from Microarray DataLaura Reck Cechinel, Rachael Ann Batabyal, Giana Blume Corssac, et al.
Frontiers in Oncology|March 1, 2021
<i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, et al.
Psychotherapy and Psychosomatics|August 11, 2006
Alexithymia in obsessive-compulsive disorder - results from a family studyHans Joergen Grabe, Stephan Ruhrmann, Susan Ettelt, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 4, 2018
The Medical Necessity of Comprehensive Patch TestingTian Hao Zhu, Raagini Suresh, Erin Warshaw, et al.
Molecular Oncology|March 9, 2023
Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patientsMustafa Abdo, Yassine Belloum, David Heigener, et al.
JCI Insight|November 24, 2020
Mitophagy protects β cells from inflammatory damage in diabetesVaibhav Sidarala, Gemma L Pearson, Vishal S Parekh, et al.
Pageof 152

Showing results (1251-1260 of 1,518) with videos related to

Sort By:
Pageof 152
European Journal of Cancer (Oxford, England : 1990)|August 23, 2020
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)Yung-Jue Bang, Talia Golan, Laetitia Dahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancerSuresh S Ramalingam, David R Spigel, David Chen, et al.
Molecular Cancer Therapeutics|January 27, 2016
Bevacizumab Prevents Brain Metastases Formation in Lung AdenocarcinomaAysegül Ilhan-Mutlu, Matthias Osswald, Yunxiang Liao, et al.
JTO Clinical and Research Reports|November 24, 2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Takashi Seto, Martin Reck, et al.
Biomedicines|November 25, 2023
Circulating Total Extracellular Vesicles Cargo Are Associated with Age-Related Oxidative Stress and Susceptibility to Cardiovascular Diseases: Exploratory Results from Microarray DataLaura Reck Cechinel, Rachael Ann Batabyal, Giana Blume Corssac, et al.
Frontiers in Oncology|March 1, 2021
<i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, et al.
Psychotherapy and Psychosomatics|August 11, 2006
Alexithymia in obsessive-compulsive disorder - results from a family studyHans Joergen Grabe, Stephan Ruhrmann, Susan Ettelt, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 4, 2018
The Medical Necessity of Comprehensive Patch TestingTian Hao Zhu, Raagini Suresh, Erin Warshaw, et al.
Molecular Oncology|March 9, 2023
Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patientsMustafa Abdo, Yassine Belloum, David Heigener, et al.
JCI Insight|November 24, 2020
Mitophagy protects β cells from inflammatory damage in diabetesVaibhav Sidarala, Gemma L Pearson, Vishal S Parekh, et al.
Pageof 152